Concepedia

Markus Pröls

MP

Statistics

Publications

7

Citations

1.2K

H-Index

7

Active since

2005

Affiliations

Dr Falk Pharma (Germany)(Current)

Medizinische Hochschule Hannover

Ludwig-Maximilians-Universität München

Karolinska University Hospital

Helsinki University Hospital

Markus Pröls is an author at Dr Falk Pharma (Germany) specializing in pharmacotherapy, liver disease, and budesonide therapy.

Publications per year

2005–2020

7

Publications

7

Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis

Michael P. Manns, Marek Woynarowski, Wolfgang Kreisel et al. · Gastroenterology · 2010 · 443 citations · Full text

, , +13

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Peter Fickert, Gideon M. Hirschfield, Gerald Denk et al. · Journal of Hepatology · 2017 · 287 citations · Full text

, , +17

Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents

Marek Woynarowski, Antal Németh, Yaacov Baruch et al. · The Journal of Pediatrics · 2013 · 124 citations

, , +12

A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA

Gideon M. Hirschfield, Ulrich Beuers, Limas Kupčinskas et al. · Journal of Hepatology · 2020 · 105 citations · Full text

, , +17

Budesonide in previously untreated autoimmune hepatitis

Johannes Wiegand, Andreas Schüler, Stephan Kanzler et al. · Liver International · 2005 · 104 citations · Full text

, , +17

1–5 of 7